| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.0M | -50.1% |
| SG&A Expense | $12.5M | +38.1% |
| Operating Income | -$13.6M | +79.4% |
| Pre-tax Income | -$27.3M | -109.2% |
| Income Tax | -$18.3M | -122.5% |
| Net Income | -$9.0M | -104.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $23.8M | -24.3% |
| Total Assets | $340.6M | -7.9% |
| Current Liabilities | $2.3M | -43.7% |
| Total Liabilities | $72.7M | -38.3% |
| Stockholders' Equity | $267.9M | +6.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.6M | +76.8% |
| Capital Expenditures | $18K | -5.5% |
| Investing Cash Flow | -$17.8M | -77.3% |
| Financing Cash Flow | $17.2M | -72.2% |
| Free Cash Flow | -$5.7M | +76.7% |